secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2024-09-24T23:59:59+00:00
Accession:  0001493152-24-037948
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics enters 5-year MSA with Charles River Labs for development and manufacturing services
--------------------------------------------------------------------------------

- Master Services Agreement with Charles River Laboratories effective September 19, 2024.
- Term expires September 19, 2029; services and fees set via future Statements of Work.
- Covers development and CDMO services including cell/gene therapy products.
- Either party can terminate on 90 days' notice; material breach cure period also 90 days.
- Standard confidentiality, IP, warranty, and indemnity terms; financial caps redacted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224037948/0001493152-24-037948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224037948/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer